Giselle Debs
Internal Medicine · Pembroke Pines, FLNPI 1538457304
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, AstraZeneca. That places this record below the midpoint for internal medicine clinicians in FL, where the typical reported total is $316.
Across 1 payment — averaging $110.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$110
Across 1,105 payments — averaging $1577.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson$679K
- AbbVie$262K
- Teva Pharmaceuticals USA, Inc.$170K
- Sanofi US Services Inc.$168K
- Biohaven Pharmaceuticals, Inc.$119K
- GSK$116K
- plus $229K from 10 others
What the payments were for
- Food & beverage$110100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $110 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$110
How this compares
$110 in reported general payments places this provider in the 25th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TradjentaLinagliptin | 230 | $115,585 |
| EliquisApixaban | 159 | $87,913 |
| XareltoRivaroxaban | 113 | $61,017 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 11 | $41,938 |
| TrulicityDulaglutide | 31 | $38,274 |
| EntrestoSacubitril/Valsartan | 48 | $31,582 |
| JentaduetoLinagliptin/Metformin Hcl | 58 | $28,986 |
| LinzessLinaclotide | 40 | $20,677 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 43 | $20,604 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 194 | $19,080 |
| Pregabalin | 126 | $14,343 |
| BrilintaTicagrelor | 30 | $12,796 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 82 | $11,710 |
| Insulin Aspart FlexpenInsulin Aspart | 64 | $11,176 |
| FarxigaDapagliflozin Propanediol | 20 | $11,064 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta, Farxiga | $110 | $23,85950 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Pembroke Pines
- Manuel GonzalezPembroke Pines$37K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.